The US Food and Drug Administration (FDA) is preparing to advance the use of structured benefit-risk assessments in its decision making under its commitments in the recently reauthorized Prescription ...
The US Food and Drug Administration (FDA) on Tuesday announced it will hold a public meeting on 16 May to evaluate ways to apply FDA’s benefit-risk framework throughout the human drug lifecycle and ...
Dublin, May 07, 2026 (GLOBE NEWSWIRE)-- The "Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments - What to Consider Training Course (Sept 21st - Sept 25th, ...
This workshop series provided a venue for stakeholders to discuss structured approaches to characterize and communicate the sources of uncertainty in benefit-risk assessment in drug development and ...
US market availability for Tavneos continues as Amgen works with the FDA to address concerns over trial data assessment and known hepatotoxicity risks. Amgen is providing prescribers with updated ...
In a recent study posted to the medRxiv* preprint server, researchers modeled the benefit-risk of Moderna’s coronavirus disease 2019 (COVID-19) mRNA-1273 vaccine. Study: BENEFIT-RISK ASSESSMENT OF ...
Discover crucial aspects of operational risk, from its causes and management strategies to examples and assessment techniques ...
The "Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments - What to Consider (Sept 21st - Sept 25th, 2026)" training has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results